why choose us

First received: February 08, 2023

Clinical Trial: Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms

Study Status: Completed

Recruit Status: RECRUITING

Condition: Myelodysplastic Syndromes

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Single Arm Study of Luspatercept for the Treatment of Anemia in Lower Risk Myelodysplastic Syndromes (MDS) or Non-Proliferative Myelodysplastic Syndromes/ Myeloproliferative Neoplasms

Brief Summary: The purpose of the study is to see if participants with anemia due to their type of MDS or MDS/MPN will experience a more decreased need for regular blood transfusions if they take luspatercept plus best supportive care, and what effect, good and/or bad, luspatercept has on them and their anemia due to MDS or MDS/MPN.The safety and tolerability of luspatercept will also be evaluated in this study.

Read more